Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

LAZ Lazard, Inc.
$39.16 2.11% +0.81
Notify me if price changes either direction
Interactive Brokers Logotype

Buy LAZ stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Lazard, Inc. (LAZ)

Loading

Key Stats

Market cap. 3.8B
Enterprise value 4.9B
Trailing PE 23.242424
Forward PE 11.936145
PEG Ratio -0.23854066736842
Enterprise to EBITDA 10.857709385277
Enterprise to revenue 1.494
Price to book MRQ 3.9475036
Price to sales TTM 1.1464418

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 3.3B
EBITDA 449.4M
Diluted EPS TTM 1.65
Total Cash (MRQ) 1.3B
Current ratio (MRQ) 4.24
Operating Cash Flow (TTM) 700.3M

LAZ trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent LAZ News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.